&nbsp;

Premieres-Nations-Depistage-cancer-sein-print.pdf

New

Jul 2025

Document

Premieres-Nations-Depistage-cancer-poumon-print.pdf

New

Jul 2025

Document

Poster-mciq.zip

New

Jul 2025

Document

pebcES1-25f.pdf

New

Sep 2025

Regimen

PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Neoadjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PEMB(RT)

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2025

Drug

zolbetuximab

Other Name(s): Vyloy®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Sep 2025

Regimen

PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Adjuvant, Curative

Drugs Used:

pembrolizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2025

Primary Care Reports

Regimen

ZOLB(MNT)

Cancer Type:

Gastrointestinal,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Zolbetuximab - First-line Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Drugs Used:

zolbetuximab